Related Experiment Video
Updated: Jan 16, 2026

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+
Published on: May 19, 2017
Multitargeted Caffeic Acid Derivatives Inhibit Cardiac RyR2- and NaV1.5- Channels but Stimulate SERCA2a Pump Activity
Gyuzel Y Mitronova1,2, Christine Quentin1, Vladimir N Belov1
1Department of NanoBiophotonics, Max Planck Institute for Multidisciplinary Sciences, Am Fassberg 11, 37077 Göttingen, Germany.
Abstract:
Heart beat relies on coordinated calcium regulation through RyR2 and SERCA2a activity, as well as impulse propagation mediated by NaV1.5 activity. Here, we present small molecules combining a 1,4-benzothia- or 1,4-benzoxazepine scaffold and a 3-(3,4-dihydroxyphenyl)-2-propenoic acid residue of which five compounds (4, 9, 10, 12, and 13) reduced cardiac RyR2 activity and stimulated SERCA2a activity in our cell systems. The acceleration of SERCA2 activity was particularly enhanced by cyanoborane derivatives 11-13. The substantial impact on SERCA2 activation relates to the presence of polar (zwitterionic) N-B fragments, which can increase the binding affinity to SERCA2 and result in a more efficient activation. Compounds 12 and 13 at a concentration of 10 μM additionally reduced NaV1.5 activity in Chinese hamster ovary (CHO) cells, indicating a multitargeted drug property. We propose that the multitargeted actions of these novel compounds have the potential to enhance heart failure therapy, particularly in personalized treatment approaches.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers